UNII 7FLD91C86K

EDETATE DISODIUM

Unique Ingredient Identifier 7FLD91C86K is listed as a ingredient substance
Unii7FLD91C86K
Preferred Substance NameEDETATE DISODIUM
Rn6381-92-6
NcitC61741
Rxcui1310470
Pubchem636371
Molecular FormulaC10H12N2O8.2Na.2H.2H2O
InchikeyOVBJJZOQPCKUOR-UHFFFAOYSA-L
Smiles[H+].[H+].O.O.[Na+].[Na+].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O
Unii TypeINGREDIENT SUBSTANCE
RN6381-92-6
NCITC61741
RXCUI1310470
MFC10H12N2O8.2Na.2H.2H2O
INCHI KEYOVBJJZOQPCKUOR-UHFFFAOYSA-L
SMILES[H+].[H+].O.O.[Na+].[Na+].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O

Alternate Names

Dosage Forms

UNII 7FLD91C86K EDETATE DISODIUM is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,INFILTRATIONINJECTION0.011 %
AN,INFILTRATIONSOLUTION, INJECTION NA
AURICULAR (OTIC)SOLUTION0.1 %
AURICULAR (OTIC)SUSPENSION NA
CAUDAL BLOCKINJECTION NA
EPIDURALINJECTION0.011 %
IM - IVINJECTABLE0.05 %
IM - IVINJECTION0.5 MG/1ML
IM - IVINJECTION0.05 %
IM - IVLIQUID, WATER, STERILE, FOR INJECTION0.01 %
IM - IVSOLUTION, INJECTION0.05 %
IM - IV - SCINJECTION0.2 %
IM - SCINJECTION0.2 %
INHALATIONSOLUTION0.1 mg/3mL
INHALATIONSOLUTION0.05 %W/V
INHALATIONSOLUTION, FOR INHALATION0.005 %
INHALATIONSUSPENSION0.19 mg/2mL
INHALATIONSUSPENSION, FOR INHALATION0.01 %
INTRA-ARTERIALINJECTION NA
INTRA-ARTICULARINJECTABLE0.01 %
INTRA-ARTICULARINJECTION0.05 %
INTRA-ARTICULARINJECTION, SUSTAINED ACTION NA
INTRABURSALINJECTION0.01 %
INTRACARDIACINJECTION0.2 mg/1mL
INTRACARDIACINJECTION NA
INTRACAVITARYINJECTION NA
INTRADERMALINJECTION NA
INTRADERMALINJECTION, SUSTAINED ACTION NA
INTRADISCALPOWDER, FOR INJECTION SOLUTION NA
INTRALESIONALINJECTABLE0.01 %
INTRALESIONALINJECTION0.05 %
INTRALESIONALINJECTION, SUSTAINED ACTION NA
INTRAMUSCULARINJECTABLE0.01 %W/V
INTRAMUSCULARINJECTION10 %W/V
INTRAMUSCULARINJECTION0.2 mg/1mL
INTRAMUSCULARINJECTION, SOLUTION0.02 %
INTRAMUSCULARINJECTION, SUSTAINED ACTION NA
INTRAMUSCULARSOLUTION, INJECTION0.1 %W/V
INTRASYNOVIALINJECTION NA
INTRASYNOVIALINJECTION, SUSTAINED ACTION NA
INTRAUTERINESOLUTION NA
INTRAVASCULARINJECTION0.04 %
INTRAVENOUSEMULSION, INJECTION0.005 %
INTRAVENOUSINFUSION0.01 %
INTRAVENOUSINJECTABLE1.1 mg/mL
INTRAVENOUSINJECTABLE0.01 %
INTRAVENOUSINJECTION10 %
INTRAVENOUSINJECTION0.5 MG/1ML
INTRAVENOUSINJECTION, SOLUTION0.25 MG/1ML
INTRAVENOUSLIQUID, WATER, STERILE, FOR INJECTION0.5 MG/1ML
INTRAVENOUSLIQUID, WATER, STERILE, FOR INJECTION0.01 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION0.32 MG/1ML
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION0.1 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED1.88 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.5 MG/ML
INTRAVENOUSSOLUTION0.05 %
INTRAVENOUSSOLUTION, INJECTION0.11 %
IONTOPHORESISPATCH, CONTROLLED RELEASE0.1 MG
IV - SCSOLUTION, INJECTION0.02 %
IV(INFUSION)EMULSION, INJECTION0.05 %
IV(INFUSION)INJECTABLE0.02 %
IV(INFUSION)INJECTION1 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED1.88 %
IV(INFUSION)POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED0.04 %
IV(INFUSION)SOLUTION, INJECTION0.04 %
NASALSOLUTION0.1 %
NASALSOLUTION, SPRAY0.05 %
NASALSOLUTION, SPRAY, METERED, PUMP0.007 %
NASALSPRAY106 UG/SPRAY
NASALSPRAY0.1 %
NASALSPRAY, METERED68.5 MCG/SPRAY
NASALSPRAY, METERED0.5 %
NERVE BLOCKINJECTION0.011 %
NERVE BLOCKSOLUTION, INJECTION NA
OPHTHALMICDROPS0.05 %
OPHTHALMICEMULSION0.3 %W/V
OPHTHALMICGEL0.055 %
OPHTHALMICSOLUTION1.27 MG/1ML
OPHTHALMICSOLUTION0.5 %
OPHTHALMICSOLUTION, DROPS0.15 mg/1mL
OPHTHALMICSOLUTION, DROPS0.1 %
OPHTHALMICSOLUTION, DROPS0.01 %W/V
OPHTHALMICSOLUTION/ DROPS0.1 MG/1ML
OPHTHALMICSOLUTION/DROPS0.015 %
OPHTHALMICSUSPENSION0.13 %
OPHTHALMICSUSPENSION, DROPS0.1 %
ORALCAPSULE1 MG
ORALCAPSULE (IMMED./COMP. RELEASE)1 MG
ORALCAPSULE, SOFT GELATIN1 MG
ORALCONCENTRATE3 MG/1ML
ORALEMULSION NA
ORALLIQUID0.5 MG/1ML
ORALPOWDER, FOR SOLUTION NA
ORALPOWDER, FOR SUSPENSION3 MG/5ML
ORALSOLUTION210 MG/160ML
ORALSOLUTION5.53 MG/5ML
ORALSOLUTION2.5 mg/5 mL
ORALSOLUTION, ELIXIR0.005 %
ORALSOLUTION, FOR INHALATION0.055 MG/.5ML
ORALSOLUTION/DROPS0.1 %W/V
ORALSUSPENSION7.5 MG/5ML
ORALSUSPENSION, DROPS1 MG/2.5ML
ORALSUSPENSION, EXTENDED RELEASE10 MG/5ML
ORALSUSPENSION, FOR INHALATION0.2 MG/2ML
ORALSUSPENSION, SYRUP, SUSTAINED ACTION0.01 %
ORALSYRUP25 MG/5ML
ORALTABLET4 MG
ORALTABLET0.2 ug
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE0.25 MG
ORALTABLET, COATED0.21 MG
ORALTABLET, DELAYED ACTION100 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED100 MG
ORALTABLET, EFFERVESCENT, FOR SOLUTION0.9 MG
ORALTABLET, EXTENDED RELEASE5 MG
ORALTABLET, FILM COATED4 MG
ORALTABLET, ORALLY DISINTEGRATING3 MG
OTICSUSPENSION0.01 %
RECTALEMULSION, AEROSOL FOAM0.085 %
RECTALENEMA0.1 %
RECTALSOLUTION0.04 %
RESPIRATORY (INHALATION)INHALANT0.011 %
RESPIRATORY (INHALATION)SOLUTION0.05 %
RESPIRATORY (INHALATION)SOLUTION, FOR INHALATION0.03 %
RESPIRATORY (INHALATION)SPRAY0.05 %
RESPIRATORY (INHALATION)SUSPENSION, FOR INHALATION0.02 %
SOFT TISSUEINJECTION0.05 %
SUBCUTANEOUSINJECTABLE0.1 %
SUBCUTANEOUSINJECTION0.2 %
SUBCUTANEOUSINJECTION0.2 mg/1mL
SUBCUTANEOUSINJECTION, SOLUTION0.02 %
SUBCUTANEOUSSOLUTION, INJECTION0.11 %
TOPICALCREAM0.05 %W/W
TOPICALCREAM, AUGMENTED0.1 %W/W
TOPICALCREAM, EMULSION, SUSTAINED RELEASE0.05 %W/W
TOPICALDROPS0.05 %W/V
TOPICALEMULSION0.11 %W/W
TOPICALEMULSION, AEROSOL FOAM0.05 %W/W
TOPICALEMULSION, CREAM0.1 %W/W
TOPICALFILM, CONTROLLED RELEASE14 MG
TOPICALGEL0.17 %W/W
TOPICALLOTION0.12 %W/V
TOPICALLOTION0.05 %W/W
TOPICALOINTMENT0.007 %W/W
TOPICALOPHTHALMIC SUSPENSION DOSAGE FORM0.06 %W/V
TOPICALPATCH7 MG
TOPICALPATCH, CONTROLLED RELEASE NA
TOPICALPOWDER, FOR SOLUTION NA
TOPICALSOLUTION1.27 MG/1ML
TOPICALSOLUTION0.1 %W/W
TOPICALSOLUTION, DROPS0.05 %W/V
TOPICALSOLUTION/DROPS0.01 %W/V
TOPICALSUSPENSION NA
TOPICALSUSPENSION, DROPS0.1 %W/W
TRANSDERMALGEL0.06 %
URETERALSOLUTION NA
URETHRALSOLUTION NA
VAGINALCREAM0.05 %W/W
VAGINALCREAM, EMULSION, SUSTAINED RELEASE0.05 %
VAGINALEMULSION, CREAM0.05 %
VAGINALGEL0.05 %

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.